Resources

Sector
Pharma

Resources

White Paper: Hot topics in Pharma

The pressure to innovate is especially high, with patents for important, best selling biologics drugs on the way to expiry. As blockbuster brands lose exclusivity, makers of originator drugs are vying with companies producing new, cheaper biosimilar alternatives to retain shares of the market. Efforts to replenish R&D pipelines and…

White Paper: The role of digital tools in medical affairs

As digital technology has fastly grown, so has the role of medical affairs, a trend that will continue in the future. Medical affairs professionals are no longer solely responsible for medical accuracy, but are now driving overall medical strategy and need as much support as possible to carry out these…

Creating clinical trial dashboards accessible for clinicians

Create a Clinical Trial Visualization Platform to transform scientific publications into an accessible and interactive format for clinicians and patients.

Find experts of the future

How to find experts of the future with access to relevant information and insights that will help inform future strategies.

Understand cancer research activities

How to track and understand cancer related activity across publications, grants and more.

Easily find the right experts for medical affairs with the KOL custom dashboard

How to find key opinion leaders (KOL) for every medical affairs department, therapy areas and around specific medication.

Automate literature gap analysis to improve patient outcomes

The Dimensions / Pfizer collaboration that combined AI and human intelligence to help find drug treatments for prostate cancer.
Dimensions Dashboards

Undertake complex landscape analysis at speed

How to quickly horizon scan any chosen topic or field with easy to understand visualisations.

Establish a fast, accurate drug landscape for specific targets

How to accurately analyse the drug landscape for specific targets to reduce the risk of efficacy failure and take more drugs to market.
1
2

Sign up for our newsletter